Molecular Partners Highlights Multispecific Radio-DARPins Formatted As Bispecific Or 2-In-1 DuoDARPin To Address Tumor Heterogeneity

Benzinga Newsdesk www.benzinga.com Positive 91.6%

Neg 0% Neu 0% Pos 91.6%

Developing bispecific Radio-DARPins to engage multiple tumor targets simultaneously, improving precision and therapeutic efficacy
Presentation outlines Radio-DARPins’ ability to match target and disease biology for improved outcomes

Comments

No comments yet. Be the first!